MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cmi.2026.09.005

Медицинская библиотека · Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026

Standardising outcomes in paediatric bloodstream infection antibiotic trials: a scoping review.

Wen Sophie C H, de Souza Sabrina, Thomas Elizabeth T, Ullman Amanda, Gwee Amanda, Campbell Anita J, Bowen Asha C, Blyth Christopher C, Spurling Geoff, Clark Julia E, Schlapbach Luregn, Harris Patrick N A, Paterson David, Irwin Adam

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

The lack of a standardised framework for outcome measures in paediatric antimicrobial trials for bloodstream infections (BSIs) limits comparability and evidence synthesis.

OBJECTIVES

To identify and categorise the outcome measures reported in paediatric antibiotic trials for Staphylococcus aureus, Streptococcus pyogenes, and gram-negative BSIs to inform future paediatric BSI trial design and core outcome set development, and to identify patient-reported outcome measures (PROMs).

METHODS

DATA SOURCES: MEDLINE, Embase, CENTRAL, and grey literature (2010 to December 2024).

STUDY ELIGIBILITY CRITERIA: Interventional antibiotic trials, clinical guidelines and consensus statements for paediatric BSI, and qualitative studies on PROMs.

PARTICIPANTS

Children aged 0-18years, including neonates.

INTERVENTIONS: Antibiotic therapy for BSIs, including systemic antibiotic therapy and antibiotic lock therapy. Assessment of risk of bias: Not performed, consistent with scoping review methodology.

METHODS

of data synthesis: Two reviewers independently screened and extracted data. Outcomes were categorised thematically.

RESULTS

Of 22,622 records (15,960 peer-reviewed; 6,662 grey literature), 58 studies met inclusion criteria, comprising 14,424 paediatric and neonatal patients. Neonatal sepsis was the most frequently studied condition (n= 28, 51%). Clinical and microbiological outcomes were reported in 50 (86%) and 48 (83%) studies respectively. Combined outcomes in 34 (59%). Safety outcomes were reported in 35 (60%) studies, surrogate outcomes in 22 (38%), pharmacokinetic measures in 12 (21%), cost-related outcomes in 2 (3%), and acceptability in 1 (2%). Subjective clinical outcomes were reported in 2 studies (3%). A total of 514 distinct outcome subcategories were identified. No studies reported PROMs.

CONCLUSIONS

Outcome reporting in paediatric BSI trials is highly variable, and PROMs were not reported. Developing a core outcome set incorporating standardised and patient-centred outcomes is needed to improve comparability and support evidence-based decision-making.

Для цитирования: Wen Sophie C H, de Souza Sabrina, Thomas Elizabeth T, Ullman Amanda, Gwee Amanda, Campbell Anita J, Bowen Asha C, Blyth Christopher C, Spurling Geoff, Clark Julia E, Schlapbach Luregn, Harris Patrick N A, Paterson David, Irwin Adam. Standardising outcomes in paediatric bloodstream infection antibiotic trials: a scoping review.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2026. DOI: 10.1016/j.cmi.2026.09.005.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.